Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca's Scientific Advisory Board |
April 07, 2022 | April 2022 Bond Updates |
SÖDERTÄLJE, Sweden, April 7, 2022 /PRNewswire/ -- Anocca, a biotechnology company using its precision biology platforms to engineer a broad portfolio of innovative T cell therapeutics, today announced the appointment of Dr. Michael Kalos to its Scientific Advisory Board (SAB). Dr. Kalos... |
View more at: https://www.prnewswire.com:443/news-releases/renowned-immunotherapy-expert-dr-michael-kalos-joins-anoccas-scientific-advisory-board-301519316.html |
Related News |